Unilateral Epidural Block Versus Ultrasound Guided Combined Femoro-sciatic Nerves Block for Patients With Low Ejection Fraction
Launched by AIN SHAMS UNIVERSITY · Aug 16, 2022
Trial Information
Current as of April 30, 2025
Unknown status
Keywords
ClinConnect Summary
Group A ;( Unilateral epidural anesthesia group) Forty patients with low ejection fraction (30-40%) will do elective insertion of nail tibia for fixation of fracture shaft tibia using unilateral epidural anesthesia.
Group B;;( Ultrasound guided femoro/ sciatic nerve block group) Forty patients with low ejection fraction (30-40%) will do elective insertion of nail tibia for fixation of fracture shaft tibia by femoral/sciatic nerve block using ultrasound guidance.
For each patient, onset of sensory and motor block, degree of motor block, sign of sensory block in the contralateral lower limb...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 to 60 years old.
- • Patients scheduled for elective insertion of nail tibia for fixation of fracture shaft tibia.
- • Patients with low ejection fraction (30-40%).
- Exclusion Criteria:
- • Patient refusal
- • Uncooperative patient
- • Unconscious patients
- • Cases with head trauma
- • History of relevant drug allergy to local anesthetics
- • Local infection at the site of the block
- • Patients with coagulopathies and impaired platelet functions
- • Patients with hemodynamic instability
- • Previous neurological deficit in lower limb and previous femoral artery grafts or injuries.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials